Valvular & structural heart disease

Mitral annular disjunction and its progression during childhood in Marfan syndrome

Eur Heart J Cardiovasc ImagingPublished Retrospective cohort study

Authors' conclusion

MAD was common in pediatric MFS and was associated with aortic root dilation. MAD detection by echocardiography and CMR was highly reliable, suggesting that routine assessment in MFS is feasible. MAD was present in neonates and progressed over time but remained constant when indexing by height.

Study context

Population
Patients <21 years old with Marfan syndrome (MFS) (2010 Ghent criteria and pathogenic FBN1 variant or ectopia lentis)
Participants
185 eligible patients
Outcome
Prevalence of MAD (MV-LV separation ≥2 mm), its diagnostic yield by echocardiography and CMR, and its progression during childhood

Main finding

As reported in the abstract

MAD prevalence

Mitral annular disjunction (MAD) detected

60%

110/185

Observational data: associations, not effects.

Further findings

MV prolapse (MVP) and MAD overlap

MVP in MAD
48% (53/110)
MAD in MVP
90% (53/59)

Agreement of MAD detection, CMR vs echocardiography

Overall agreement
96%
Kappa
0.89, P < 0.001
Estimate bias
0.32 mm (95% CI 0.00, 0.65)

ICC (reliability)

Echocardiography
0.97 (95% CI 0.93, 0.98)
CMR
0.92 (95% CI 0.79, 0.97)
Between modalities
0.91 (95% CI 0.85, 0.94)

Association of MAD with aortic root dilation

MAD associated with aortic root dilation
P < 0.001

Longitudinal change of MAD · median 5.5 years (IQR 3.1, 7.5 years)

MAD increase
+0.18 mm/year (95% CI +0.14, +0.22)
MAD indexed by height (constant)
+0.0002 mm/m/year (95% CI −0.0002, +0.0005 mm/m/year)
  • Univariable mixed-effects linear regression

Original publication

Mitral annular disjunction and its progression during childhood in Marfan syndrome. Eur Heart J Cardiovasc Imaging. Published 10 May 2024. doi:10.1093/ehjci/jeae125

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.